Karolina A Klucznik , Thomas Ravkilde , Simon Skouboe , Ditte S Møller , Steffen Hokland , Paul Keall , Simon Buus , Lise Bentzen , Per R Poulsen
{"title":"基于锥束ct的放射治疗中前列腺运动和剂量畸变的估计","authors":"Karolina A Klucznik , Thomas Ravkilde , Simon Skouboe , Ditte S Møller , Steffen Hokland , Paul Keall , Simon Buus , Lise Bentzen , Per R Poulsen","doi":"10.1016/j.phro.2025.100798","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and purpose</h3><div>Intra-fractional prostate translational and rotational (6DoF) motion can cause dose distortions. As intra-fractional motion monitoring is often unavailable, this study compares three methods to use pre- and post-treatment cone beam CTs (CBCT) to estimate prostate positioning errors during treatment and their dosimetric impact.</div></div><div><h3>Material and Methods</h3><div>Eighteen patients received prostate radiotherapy with pre-treatment CBCT setup. For 7–10 fractions per patient (total:174), triggered kV-images were acquired every 3 s during beam-on and a CBCT was acquired post-treatment. The 6DoF prostate position error during treatment was determined from the kV-images (ground truth) and estimated from the CBCTs assuming a static position as in the pre-CBCT(Scenario1), a linear drift between pre- and post-CBCT position(Scenario2) or a static position as in the post-CBCT(Scenario3). The positioning errors and prostate dose from each scenario were compared with the ground truth.</div></div><div><h3>Results</h3><div>Scenario1 was inferior to the others with prostate position root-mean-square errors of 1.1 mm(LR), 1.7 mm(AP) and 1.8 mm(CC). Scenario2 and 3 were similarly accurate with root-mean-square errors of 0.5 mm(LR), 0.9 mm(AP) and 0.8 mm(CC) (Scenario2) and 0.6 mm(LR), 1.1 mm(AP) and 0.9 mm(CC) (Scenario3). The prostate position errors reduced the CTV D<sub>99.5%</sub> by more than 2/3 % at 24/15 % of the fractions, respectively. The sensitivity in detecting these dose deficits was low for Scenario1 (9–16 %) and considerably higher for Scenario2 (68–76 %) and Scenario3 (86–91 %). All scenarios showed high specificity (93–99 %).</div></div><div><h3>Conclusion</h3><div>Using the post-CBCT prostate position, acquired right after treatment, performed best in detecting intra-fractional prostate position errors and CTV dose deficits. It offers a scalable and conservative estimate of motion-induced dose distortions.</div></div>","PeriodicalId":36850,"journal":{"name":"Physics and Imaging in Radiation Oncology","volume":"35 ","pages":"Article 100798"},"PeriodicalIF":3.4000,"publicationDate":"2025-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cone-beam CT-based estimations of prostate motion and dose distortion during radiotherapy\",\"authors\":\"Karolina A Klucznik , Thomas Ravkilde , Simon Skouboe , Ditte S Møller , Steffen Hokland , Paul Keall , Simon Buus , Lise Bentzen , Per R Poulsen\",\"doi\":\"10.1016/j.phro.2025.100798\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and purpose</h3><div>Intra-fractional prostate translational and rotational (6DoF) motion can cause dose distortions. As intra-fractional motion monitoring is often unavailable, this study compares three methods to use pre- and post-treatment cone beam CTs (CBCT) to estimate prostate positioning errors during treatment and their dosimetric impact.</div></div><div><h3>Material and Methods</h3><div>Eighteen patients received prostate radiotherapy with pre-treatment CBCT setup. For 7–10 fractions per patient (total:174), triggered kV-images were acquired every 3 s during beam-on and a CBCT was acquired post-treatment. The 6DoF prostate position error during treatment was determined from the kV-images (ground truth) and estimated from the CBCTs assuming a static position as in the pre-CBCT(Scenario1), a linear drift between pre- and post-CBCT position(Scenario2) or a static position as in the post-CBCT(Scenario3). The positioning errors and prostate dose from each scenario were compared with the ground truth.</div></div><div><h3>Results</h3><div>Scenario1 was inferior to the others with prostate position root-mean-square errors of 1.1 mm(LR), 1.7 mm(AP) and 1.8 mm(CC). Scenario2 and 3 were similarly accurate with root-mean-square errors of 0.5 mm(LR), 0.9 mm(AP) and 0.8 mm(CC) (Scenario2) and 0.6 mm(LR), 1.1 mm(AP) and 0.9 mm(CC) (Scenario3). The prostate position errors reduced the CTV D<sub>99.5%</sub> by more than 2/3 % at 24/15 % of the fractions, respectively. The sensitivity in detecting these dose deficits was low for Scenario1 (9–16 %) and considerably higher for Scenario2 (68–76 %) and Scenario3 (86–91 %). All scenarios showed high specificity (93–99 %).</div></div><div><h3>Conclusion</h3><div>Using the post-CBCT prostate position, acquired right after treatment, performed best in detecting intra-fractional prostate position errors and CTV dose deficits. It offers a scalable and conservative estimate of motion-induced dose distortions.</div></div>\",\"PeriodicalId\":36850,\"journal\":{\"name\":\"Physics and Imaging in Radiation Oncology\",\"volume\":\"35 \",\"pages\":\"Article 100798\"},\"PeriodicalIF\":3.4000,\"publicationDate\":\"2025-06-24\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Physics and Imaging in Radiation Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2405631625001034\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Physics and Imaging in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2405631625001034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
Cone-beam CT-based estimations of prostate motion and dose distortion during radiotherapy
Background and purpose
Intra-fractional prostate translational and rotational (6DoF) motion can cause dose distortions. As intra-fractional motion monitoring is often unavailable, this study compares three methods to use pre- and post-treatment cone beam CTs (CBCT) to estimate prostate positioning errors during treatment and their dosimetric impact.
Material and Methods
Eighteen patients received prostate radiotherapy with pre-treatment CBCT setup. For 7–10 fractions per patient (total:174), triggered kV-images were acquired every 3 s during beam-on and a CBCT was acquired post-treatment. The 6DoF prostate position error during treatment was determined from the kV-images (ground truth) and estimated from the CBCTs assuming a static position as in the pre-CBCT(Scenario1), a linear drift between pre- and post-CBCT position(Scenario2) or a static position as in the post-CBCT(Scenario3). The positioning errors and prostate dose from each scenario were compared with the ground truth.
Results
Scenario1 was inferior to the others with prostate position root-mean-square errors of 1.1 mm(LR), 1.7 mm(AP) and 1.8 mm(CC). Scenario2 and 3 were similarly accurate with root-mean-square errors of 0.5 mm(LR), 0.9 mm(AP) and 0.8 mm(CC) (Scenario2) and 0.6 mm(LR), 1.1 mm(AP) and 0.9 mm(CC) (Scenario3). The prostate position errors reduced the CTV D99.5% by more than 2/3 % at 24/15 % of the fractions, respectively. The sensitivity in detecting these dose deficits was low for Scenario1 (9–16 %) and considerably higher for Scenario2 (68–76 %) and Scenario3 (86–91 %). All scenarios showed high specificity (93–99 %).
Conclusion
Using the post-CBCT prostate position, acquired right after treatment, performed best in detecting intra-fractional prostate position errors and CTV dose deficits. It offers a scalable and conservative estimate of motion-induced dose distortions.